期刊文献+

慢性乙肝患者外周血NK细胞NKp46和NKG2A的表达 被引量:2

Expression of NKp46 and NKG2A in peripheral blood NK cells of patients with chronic hepatitis B
下载PDF
导出
摘要 目的检测免疫清除期和免疫耐受期慢性乙肝患者外周血中NK细胞频率和NK受体NKp46和NKG2A表达情况。方法分离患者和健康对照者外周血单个核细胞,流式细胞仪检测各组NK细胞频率和受体表达。结果慢性乙肝免疫清除期患者外周血NK细胞占淋巴细胞比例(10.91%±3.93%,n=21)较免疫耐受期患者(15.65%±5.58%,n=15,P=0.024)和健康者(14.23%±7.37%,n=25,P=0.011)下降,免疫清除期患者NK细胞的NKp46表达(45.45%±14.00%,n=19)较免疫耐受期患者(23.35%±6.56%,n=8,P<0.001)和健康者(31.69%±13.07%,n=20,P=0.001)明显上升,NKG2A表达(35.62%±13.20%,n=19)较免疫耐受期患者(25.57%±5.56%,n=8,P=0.038)和健康者(26.80%±10.49%,n=20,P=0.047)上升。结论慢性乙肝患者外周血NK细胞频率下降,NKp46和NKG2A表达上调,这些改变与免疫清除病毒有关。 Objective To determine the frequency of NK cells and expression of their receptors, including NKG2A and NKp46, in peripheral blood of patients with chronic hepatitis B. Methods Peripheral blood mononuclear cells (PBMC) were separated from patients and healthy controls. Frequency of NK cells and expression of their receptors were detected by flow cytometry. Results The number of NK cells in peripheral blood of chronic hepatitis B patients was less at immunoclearence phase(10.91% ± 3.93%, n=21)than at immunotolerance phase(15.65% ± 5.58%, n=15, P=0.024)and than that of healthy controls(14.23% ± 7.37%, n=25, P=0.011). In contrast, the expression level of NKp46 was significantly higher in patients at immunoclearence phase (45.45% ± 14.00%, n=19) than at immunotolerant phase(23.35% ± 6.56%, n=8, P〈0.001) and than that in healthy controls(31.69%± 13.07%, n=20, P=0.001). Moreover, the NKG2A expression level was higher in patients at immunoclearence phase (35.62% ± 13.20%, n=19) than at immunotolerant phase (25.57%±5.56%, n=8, P=0.038) and than that in healthy controls (26.80% ±10.49%, n=20, P=0.047). Conclusion The frequency of NK cells in peripheral blood of patients at immunoclearence phase is decreased whereas the expression of NKp46 and NKG2A is up-regulated, which is related to viral immunoclearence.
出处 《军医进修学院学报》 CAS 2009年第5期688-689,694,共3页 Academic Journal of Pla Postgraduate Medical School
基金 "973"课题(2007CB512804)~~
关键词 NKp46 NKG2A NK细胞 肝炎 乙型 慢性 NKp46 NKG2A NK ceils hepatitis B, chronic
  • 相关文献

参考文献1

二级参考文献21

  • 1李玉中,胡宏,王敏,王忠利,高泽斌,代溅泳,薛亚震.肝病患者血中T淋巴细胞亚群及NK细胞数量的变化[J].大连医科大学学报,2001,23(1):56-58. 被引量:8
  • 2徐志强,张鸿飞,杨晓晋,杨斌,王福生.小儿慢性乙型肝炎外周血T细胞亚群和临床病理关系的研究[J].中华实验和临床病毒学杂志,2004,18(2):142-144. 被引量:15
  • 3Alatrakchi N,Koziel MJ.Antiviral T-cell responses and therapy in chronic hepatitis B.J Hepatol,2003,39:631-634.
  • 4Lavanchy D.Hepatitis B virus epidemiology,disease burden,treatment,and current and emerging prevention and control measures.J Viral Hepat,2004,11:97-107.
  • 5Kao JH,Chen DS.Global control of hepatitis B virus infection.Lancet Infect Dis,2002,2:395-403.
  • 6Koziel MJ.The immunopathogenesis of HBV infection.Antivir Ther,1998,3(Suppl 3):13-24.
  • 7Chisari FV.Cytotoxic T cells and viral hepatitis.J Clin Invest,1997,99:1472-1477.
  • 8Jung MC,Pape GR.Immunology of hepatitis B infection.Lancet Infect Dis,2002,2:43-50.
  • 9Fei GZ,Sylvan SP,Yao GB,et al.Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B.J Viral Hepat,1999,6:219-227.
  • 10Choremi-Papadopoulou H,Panagiotou N,Samouilidou E,et al.CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS.Clin Exp Immunol,2000,119:499-506.

共引文献63

同被引文献26

  • 1Williams R. Global challenges in liver disease [J]. Hepa- tology, 2006,44 (3) : 521-526.
  • 2Lavanchy D. The global burden of hepatitis C [J]. Liver Int,2009,29 Suppl 1:74-81.
  • 3Thomas DL, Seeff LB. Natural history of hepatitis C [J]. Clin Liver Dis ,2005,9(3) :383-398.
  • 4Lohmann V, K mer F, Koch J, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line [ J ]. Science, 1999,285 (5424) : 110-113.
  • 5Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver [J]. Immunol Rev,2000,174: 5-20.
  • 6Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions [J]. J Exp Med,2002,195(1 ) :43-49.
  • 7Crotta S, Brazzoli M, Piccioli D, et al. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection [J]. J Hepatol,2010, 52(2) : 183-190.
  • 8Jouan L, Chatel-Chaix L, Melancon P, et al. Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients [J ]. J Hepatol, 2012,56 (1) : 70-77.
  • 9Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus Ns3/gA protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF [J]. Proc Natl Acad Sci U S A,2005,102(8):2992-2997.
  • 10Zhang T, Lin RT, Li Y, et al. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines [J]. Hepatology,2005,42(4) :819-827.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部